This association may caution clinicians to assess UGT1A1 variations for neonates with ABO hemolysis, and may aid in the identification of high-risk population, which is important for management and intervention of hazardous hyperbilirubinemia. The gene discussed is UGT1A1; the disease is Hyperbilirubinemia.